Skip to main content

1/2 A Phase 2 Study of Elafin (Tiprelestat) for the Treatment of Pulmonary Arterial Hypertension (PAH)

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Cardiology

Awarded By

Stanford University

Start Date

August 15, 2025

End Date

July 31, 2026
 

Administered By

Medicine, Cardiology

Awarded By

Stanford University

Start Date

August 15, 2025

End Date

July 31, 2026